The days of staring at blank Luau scripts are over. With the rise of AI coding assistants like ChatGPT and Roblox's own Luau Assist, creators can now generate complex modules, debug stubborn errors, ...

If you haven't logged into Hypixel SkyBlock since late 2025, the game you remember is gone: the 1.8.9 foundation has been replaced by the 1.21.11 engine, and the 'Year of the Witch' update has ...

Since her commissioning in 2009, HMS Daring has spent more time out of service than in it. HMS Daring (D32), the first of the Royal Navy’s six Daring-class Type 45 destroyers, is finally set to return ...

With Washington State Ferries not scheduled to receive the first of three new hybrid-electric ferries from a Florida shipyard until 2030 to 2032, passengers and ferry-served communities might wonder ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Altruist has launched artificial intelligence-powered tax planning within Hazel, its AI platform, enabling advisors to create personalized tax strategies by analyzing clients’ 1040s, pay stubs, ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...

USS Zumwalt (DDG-1000) took to sea for the first time in nearly three years after the installation of large missile tubes capable of fielding hypersonic strike weapons, USNI News has learned. Zumwalt ...